Your browser doesn't support javascript.
loading
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group.
Vergote, Ignace; Van Nieuwenhuysen, Els; De Waele, Stefanie; Vulsteke, Christof; Lamot, Caroline; Van den Bulck, Heidi; Claes, Nele; Graas, Marie-Pascale; Debrock, Guy; Spoormans, Isabelle; Vuylsteke, Peter; Honhon, Brigitte; Verhoeven, Didier; De Maeseneer, Daan; Dirix, Luc; Mebis, Jeroen; Vroman, Philippe; Denys, Hannelore; Martinez Mena, Corina; Pelgrims, Gino; Van Steenberghe, Mona; van Gorp, Toon; Gennigens, Christine.
Afiliação
  • Vergote I; Division of Gynaecological Oncology, Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium ignace.vergote@uz.kuleuven.ac.be.
  • Van Nieuwenhuysen E; Division of Gynaecological Oncology, Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • De Waele S; AZ Sint-Lucas, Gent, Belgium.
  • Vulsteke C; Integrated Cancer Center Ghent, AZ Maria Middelares, Gent, Belgium.
  • Lamot C; Center for Oncological Research (CORE), Antwerp University, Edegem, Belgium.
  • Van den Bulck H; AZ Nikolaas, Sint-Niklaas, Belgium.
  • Claes N; Imeldaziekenhuis, Bonheiden, Belgium.
  • Graas MP; AZ Sint-Jan, Brugge, Belgium.
  • Debrock G; CHC Mont Légia, Liege, Belgium.
  • Spoormans I; Ziekenhuis Oost-Limburg, Genk, Belgium.
  • Vuylsteke P; AZ Damiaan Oostende, Oostende, Belgium.
  • Honhon B; CHU UCL Sainte Elisabeth, Namur, Belgium.
  • Verhoeven D; Grand Hôpital de Charleroi, Charleroi, Belgium.
  • De Maeseneer D; AZ Klina, Brasschaat, Belgium.
  • Dirix L; AZ Sint-Lucas, Gent, Belgium.
  • Mebis J; Sint-Augustinus, Wilrijk, Belgium.
  • Vroman P; Limburgs Oncologisch Centrum, Campus Virga Jesse, Hasselt, Belgium.
  • Denys H; Oncologisch Centrum West, Veurne, Belgium.
  • Martinez Mena C; UZ Gent, Gent, Belgium.
  • Pelgrims G; CHU Saint-Pierre, Brussels, Belgium.
  • Van Steenberghe M; AZ Turnhout, Turnhout, Belgium.
  • van Gorp T; Roche nv/sa, Brussels, Belgium.
  • Gennigens C; Division of Gynaecological Oncology, Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Int J Gynecol Cancer ; 32(6): 753-760, 2022 06 06.
Article em En | MEDLINE | ID: mdl-35063943
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Atividades Cotidianas Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Atividades Cotidianas Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article